Altered Mitochondrial Base Excision Repair and Mitochondrial DNA Instability in Peripheral Leukocytes of Patients with MASLD
Authors:
- Sylwia ZiółkowskaSZSylwia Ziółkowska
- Marcin KosmalskiMarcin Kosmalski
- Bianka ŚwiderskaBŚBianka Świderska
- Agnieszka SzczypiorowskaASAgnieszka Szczypiorowska
- Kinga JarmuszKJKinga Jarmusz
- Magdalena EjsmontMEMagdalena Ejsmont
- Adam Marek WróblewskiAWAdam Marek Wróblewski
- Janusz SzemrajJSJanusz Szemraj
- Tadeusz PietrasTPTadeusz Pietras
- Aleksandra JabłkowskaAJAleksandra Jabłkowska
- Piotr CzarnyPCPiotr Czarny
Open Access
Abstract
Metabolic dysfunction-associated steatotic liver disease (MASLD) is a multifactorial metabolic disorder that is strongly associated with mitochondrial dysfunction and oxidative stress, which may potentially compromise the integrity of mitochondrial DNA (mtDNA). However, the role of the base excision repair (BER) pathway—the main mechanism responsible for repairing oxidative lesions in mitochondria—and maintaining mtDNA stability in MASLD remains poorly understood. Here, we analyzed total mRNA expression levels of key BER components in whole-blood samples, along with mitochondrial protein levels of the selected components. Additionally, we assessed the mtDNA copy number and the damage of mtDNA and nuclear DNA in peripheral leukocytes from MASLD patients and healthy controls. We found that MASLD patients differed from controls in mtDNA and nuclear DNA damage, mtDNA copy number, and selected BER-related markers. However, because the MASLD and control groups also differed substantially in age and BMI, these molecular differences should be interpreted as potentially being associated with age- and BMI-related metabolic status rather than attributable to MASLD alone. While several BER-related genes were downregulated at the mRNA level, the corresponding mitochondrial protein levels were not consistently decreased in MASLD (ProteomeXchange: PXD075974), indicating a discordance between transcriptional and protein-level regulation. These results suggest that altered mitochondrial BER and mtDNA instability in peripheral leukocytes may reflect the combined influence of MASLD, aging, obesity, and broader metabolic dysfunction.Keywords
Funding Information
- Narodowe Centrum Nauki (2019/35/O/NZ5/02502)
This publication has 82 references indexed in Scilit:
- Metabolic Dysfunction‐Associated Steatotic Liver Disease ( MASLD ): Mechanisms, Clinical Implications and Therapeutic AdvancesEndocrinology, Diabetes & Metabolism, 2025
- Liver Involvement in POLG Disease—a Multicentre Cohort Study of 202 PatientsJournal of Inherited Metabolic Disease, 2025
- Genetic variants of APEX1 p.Asp148Glu and XRCC1 p.Gln399Arg with the susceptibility of hepatocellular carcinomaJournal of Medical Virology, 2021
- Sensing, signaling and surviving mitochondrial stressCellular and Molecular Life Sciences, 2021
- Ipragliflozin Improves the Hepatic Outcomes of Patients With Diabetes with NAFLDHepatology Communications, 2021
- High nuclear expression of APE1 correlates with unfavorable prognosis and promotes tumor growth in hepatocellular carcinomaJournal of Molecular Histology, 2021
- Base Excision Repair in the MitochondriaJournal of Cellular Biochemistry, 2015
- The effect of a methyl‐deficient diet on the global DNA methylation and the DNA methylation regulatory pathwaysJournal of Applied Toxicology, 2015
- Beyond HbA1c and Glucose: the Role of Nontraditional Glycemic Markers in Diabetes Diagnosis, Prognosis, and ManagementCurrent Diabetes Reports, 2014
- Poly (ADP-Ribose) Polymerase-1 Is a Key Mediator of Liver Inflammation and FibrosisHepatology, 2013